Posted on June 14, 2023

June 14, 2023 – Cala announced today that it launched its next-generation Cala kIQ system, a wearable device that delivers therapy for neurological disorders. The San Mateo, California-based company develops the Cala Trio device for transcutaneous afferent patterned stimulation (TAPS) therapy. Cala designed the Trio device for treating tremor. Its kIQ system delivers therapy for action […]

Posted on June 12, 2023

BOSTON, June 09, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the outcomes from a recent end-of-Phase 2 meeting with the U. S. Food and Drug Administration (FDA) […]

Posted on March 29, 2023

March 23, 2023–(BUSINESS WIRE)–Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced meeting the primary endpoint on an interim analysis of a prospective, randomized, controlled study. This study, “RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor” (clinicaltrials.gov NCT05540626), demonstrated that adding TAPS therapy to […]

By Mark Honeyman My journey to DBS surgery was a long time in the making. I’ve battled essential tremor since I was a young boy. When I was 12 years old, I had to give a speech for one of my classes, and I noticed that my hands were shaking far more than even the […]

SAN MATEO, Calif.–(BUSINESS WIRE)–Cala, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has set a payment determination and benefit category for the existing unique Healthcare Common Procedure Coding System (HCPCS) code K1018 for Cala TAPS therapy, initially put […]

Posted on May 18, 2022

By Arif Dalvi, MD, MBAPalm Beach Neuroscience Institute By definition essential tremor (ET) is a monosymptomatic disease with tremor as the only symptom and without an underlying cause in the form of other neurological diagnoses. ET presents most commonly as a postural tremor of the hands, although a head or voice tremor are often seen. […]

Categories: ET Treatment

By Anthony E. Lang, M.D., F.R.C.P.(C) A number of drugs and illnesses are capable of causing tremor in their own right or worsening tremor in predisposed individuals. All of us have fine tremor, known as physiologic tremor that can be documented with sensitive recording devices. There are many factors capable of accentuating physiologic tremor to […]

Posted on August 10, 2021

By Dr. Albert Fenoy,Director, Deep Brain Stimulation ProgramAssociate Professor, Department of NeurosurgeryMcGovern Medical SchoolThe University of Texas at Houston Patients with essential tremor (ET) usually present with hand tremor, an involuntary shaking of the hands dependent on position. However, head tremor can also develop in the course of ET or present as a singular symptom. […]

Posted on June 28, 2021

Information courtesy of the Medicare Plans Resource Center Many of us find signing up for health insurance to be needlessly complicated, confusing, and stressful. Unfortunately, when it comes to signing up for Medicare while considering a specific healthcare issue such as essential tremor (ET), things aren’t much simpler. Medicare is a health insurance program provided […]

Categories: ET Treatment, Support
Posted on June 17, 2021

This official IETF Essential Tremor in Adult Patients Guidelines Advisory provides clinicians with instant access to current best practices in a clear concise format. It was developed in collaboration with Guideline Central and the IETF, and authored by: Kelly Lyons, PhD Kelli Reiling Ott, OTD, OTR/L Holly Shill, MD What’s Inside? Overview/Background/Prevalence Assessment/Screening Differential Diagnosis […]